Article Information
History
- Received August 7, 2021
- Revision received October 15, 2021
- Accepted November 1, 2021
- Published online January 19, 2022.
Copyright & Usage
© 2022 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Alba Toll, MD,
- Laura Blanco-Hinojo, PhD,
- Daniel Bergé, PhD,
- Xavier Duran, PhD,
- Irene Canosa, MHN,
- Teresa Legido, PhD,
- Federico Marmol, PhD,
- Víctor Pérez-Solà, PhD,
- Emilio Fernández-Egea, PhD,
- Anna Mané, PhD
- From the Institut de Neuropsiquiatria i Adiccions (INAD), Parc de Salut Mar, Barcelona, Spain (Toll, Bergé, Canosa, Legido, Pérez-Solà, Mané); the Fundació Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain (Toll, Bergé, Duran, Canosa, Legido, Pérez-Solà, Mané); the Centro de Investigación Biomédica en Red, Área de Salud Mental (CIBERSAM), Spain (Toll, Blanco-Hinojo, Bergé, Canosa, Pérez-Solà, Mané); the Department of Psychiatry and Forensic Medicine, Universitat Autónoma de Barcelona (UAB), Barcelona, Spain (Toll); the MRI Research Unit, Department of Radiology, Parc de Salut Mar, Barcelona, Spain (Blanco-Hinojo); the Pharmacology Unit, Department of Clinical Fundamentals, Faculty of Medicine, Barcelona University, Barcelona, Spain (Marmol); and the Department of Psychiatry and Behavioral and Clinical Neuroscience Institute, University of Cambridge, United Kingdom (Fernández-Egea)
- Correspondence to: L. Blanco, MRI Department, Parc de Salut Mar, Passeig Marítim 25-29 08003, Barcelona, Spain; laura.blanco02{at}gmail.com